Publications

5808 Results

Elevated serum CA-125: An adverse prognostic factor for survival in epithelial ovarian cancer (EOC) with minimal residual disease after second-look laparotomy (SLL)

Authors
F Muggia;PY Liu;DS Alberts;K Terada;RJ Belt;HJ Schmidt;TW Pollock;EB Weiser;DW Blayney;D Wallace;R O'Toole
Journal / Conference
ASCO 14:270(#750)
Year
1995
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8835

Survival and response to treatment in patients (pts) with metastatic melanoma from intraocular primaries (MMIP) on SWOG studies.

Authors
K Katato;PY Liu;V Sondak;LE Flaherty
Journal / Conference
ASCO 14:410(#1298)
Year
1995
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8107, SWOG-8118, SWOG-8324, SWOG-8723, SWOG-8754, SWOG-8804, SWOG-8921

Phase II trial of piroxantrone in disseminated malignant melanoma: A Southwest Oncology Group study.

Authors
J Sosman;PY Liu;A Hantel;L Flaherty;V Sondak
Journal / Conference
ASCO 14:418(#1330)
Year
1995
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9116

Autologous bone marrow transplantation (ABMT) for patients with diffuse non-Hodgkin's lymphoma: Value of augmented preparative regimens. A Southwest Oncology Group (SWOG) trial.

Authors
P Stiff;S Dahlberg;RI Fisher;A McCall;A Nademanee;SJ Forman;S Horning;K Blume
Journal / Conference
ASCO 14:388(#1209)
Year
1995
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8942

The prognostic significance of prostate specific antigen (PSA) in stage D2 prostate cancer (PC) interim evaluation of Intergroup study 0105

Authors
M Eisenberger;ED Crawford;D McLeod;M Hussain;P Loehrer;B Blumentstein
Journal / Conference
ASCO 14:235(#613)
Year
1995
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

Phase II study of taxol in patients (pts) with recurrent malignant glioma: North American Brain Tumor Consortium

Authors
M Prados;C Schold;A Spence;M Berger;L McAllister;M Mehta;M Gilbert;D Fulton;S Chang
Journal / Conference
ASCO 14:146(#281)
Year
1995
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9401 (NCCTG-90-46-52)

Local recurrence in malignant melanoma: Long-term results of the surgical trial.

Authors
C Karakousis;C Balch;M Urist;M Ross;T Smith;A Bartalucci
Journal / Conference
Proc of the 48th Annual Cancer Symposium of the Society of Surgical Oncology :6
Year
1995
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8393 (INT-0013)

Phase II evaluation of didemnin B in hormonally refractory metastatic prostate cancer. A Southwest Oncology Group study.

Authors
SK Williamson;MK Wolf;MA Eisenberger;M O'Rourke;W Brannon;ED Crawford
Journal / Conference
Investigational New Drugs 13:167-170
Year
1995
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8719

A phase II trial of piroxantrone in disseminated malignant melanoma: A Southwest Oncology Group study.

Authors
JA Sosman;LE Flaherty;PY Liu;W Fletcher;JA Thompson;A Hantel;V Sondak
Journal / Conference
Investigational New Drugs 13:83-87
Year
1995
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9116

Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: A Southwest Oncology Group study.

Authors
K Kelly;JJ Crowley;PA Bunn Jr;MB Hazuka;K Beasley;C Upchurch;GR Weiss;WJ Hicks;DR Gandara;S Rivkin;RB Livingston
Journal / Conference
Journal of Clinical Oncology 13(12):2924-2930
Year
1995
Research Committee(s)
Lung
Study Number(s)
SWOG-8812